Venclexta trial deaths force AbbVie, Roche to stop recruiting myeloma patients
Here is a great free read on Multimple Myeloma and all the info you could want.
Johnson & Johnson’s Darzalex is already on track to nab a second multiple myeloma nod in newly diagnosed patients in the U.S., but its journey with England’s cost watchdog hasn’t been so smooth.
I want to share a friend of mine whose story can give all of us with a diagnosis of multiple myeloma hope. Remember her advice, “..One laugh a day”.
We all need that in our lives.
IMF is encouraging using social media with the hashtag #MyelomaWarrior. Such posts will stream to the IMF’s “Wall of Warriors” at the Myeloma Action Month website, which also includes shareable graphics. The site also offers Myeloma Warrior-branded apparel and other items the foundation hopes will be used in “selfies” and posted on social media channels.
I guess 26.2% of effectiveness isn’t enough to move forward, but at least they are trying.